Becton Dickinson (BDX) Stock Price, Fundamentals & Analysis

What BDX does

Becton Dickinson (BDX) develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for hospitals, physicians, researchers, clinical laboratories, and the pharmaceutical industry worldwide. Its business is organised into segments such as Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences. Products range from intravenous catheters and needle-free IV connectors to infusion therapy delivery systems, medication compounding and dispensing systems, and vascular care products.

Key numbers explained

• 182.52 USD is the current share price, the amount you would pay for one share right now.
• The trailing P/E ratio of 31.6 shows how much investors pay per dollar of the company's last twelve months of earnings; a higher number often reflects higher growth expectations.
• The forward P/E ratio of 13.7 uses expected future earnings and is typically read as a more forward-looking valuation than the trailing P/E.
• 2.3% is the dividend yield, which tells you the annual cash dividend as a percentage of the share price.
• 72% of earnings are paid out as dividends, meaning the company returns most of its profit to shareholders.
• 0.28 is the beta, a measure of volatility relative to the market; a value below 1 suggests the stock tends to move less than the overall market.
• 25.1% is the price change over the last 52 weeks, showing the total return from one year ago to today.
• 49.72B USD is the market capitalisation, the total value of all outstanding shares; BDX is part of the S&P 500.

Recent news

Recent headlines mention a new Chief Information and Digital Officer joining Becton Dickinson, ongoing SEC and litigation pressure, and a discussion of whether the stock has finally hit bottom after losing more than half its value. Other articles question the magnitude of recent swings and whether a rotation away from the stock was justified.

What to watch

Investors in Becton Dickinson often monitor medical device regulation, healthcare spending trends, and product cycle launches. Because the company operates globally, currency movements and geopolitical risks can affect results. Comparing BDX with peers such as Medtronic (MDT), Johnson & Johnson (JNJ), or Viatris (VTRS) can provide context for valuation and growth expectations.